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Urtica dioica L. Stinging nettle has long been known worldwide as a medicinal 
plant. To study the benefits of the nettle in diabetic encephalopathy, the gran­
ule cell density of the dentate gyrus of diabetic rats was studied following 
administration of Urtica dioica extract. A total of 24 male albino Wistar rats 
were allocated equally to normal, diabetic, preventive and treatment groups. 
Hyperglycaemia was induced by streptozotocin (80 mg/kg) in the animals of 
the diabetic and treatment groups. One week after injection of the streptozo­
tocin the animals in the treatment group received a hydroalcoholic extract of 
Urtica dioica (100 mg/kg/day) for 4 weeks intraperitoneally. The rats of the 
preventive group received hydroalcoholic extract of U. dioica (100 mg/kg/day) 
IP for the first 5 days and an injection of streptozotocin (80 mg/kg) on the 
6th day. After 5 weeks of study all the rats were sacrificed and coronal sections 
were taken from the dorsal hippocampal formation of the right cerebral hemi­
spheres and stained with cresyl violet. The area densities of the granule cells 
were measured and compared in the four groups. The density was lower in the 
diabetic rats compared with the controls (p > 0.05). The preventive group 
showed lower cell density than the controls (p > 0.05). The densities in the 
treated rats were higher than in the diabetic rats (p > 0.05). Furthermore, the 
control and treated rats showed similar densities (p > 0.05). It seems that U. 
dioica extract can help compensate for granule cell loss in the diabetic rat 
dentate gyrus, which can ameliorate cognitive impairment in diabetes. Howev­
er, preventive use of the extract showed no significant benefit. (Folia Morphol 
2008; 67: 196–204) 
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INTRODUCTION 
Diabetes mellitus is one of the most common 
serious metabolic disorders in humans. Increasing 
evidence has shown that diabetes may be associat­
ed with learning and memory deficiency in humans 
[5, 6, 19]. Studies examining the effects of strepto­
zotocin-induced diabetes on memory function in 
mice and rat models have also shown impairment 
of memory retention and retrieval as compared to 
non-diabetic controls [3, 4, 9, 27]. 
It has been suggested that the dentate gyrus, 
which is a part of the hippocampal formation, plays 
an important role in learning and memory by pro­
cessing and representing spatial information on the 
basis of conjunctive encoding, pattern separation 
and encoding of spatial information in conjunction 
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with the CA3 region [16]. In addition, it is now well 
documented that new neurons are continuously 
being produced in the dentate gyrus of adult mam­
mals, a process known as “adult neurogenesis” [10]. 
Although the exact mechanism causing the cog­
nitive disorders of diabetes has not yet been clearly 
understood, some evidence suggests that changes 
in the granule cell and its proliferating precursors in 
the dentate gyrus are involved [2, 13, 24]. A granule 
cell decrease was found in the hilus of the dentate 
gyrus in diabetic mice compared with controls [2]. 
During the last few years consideration has been 
given to various strategies to prevent and treat dia­
betic encephalopathy, which is characterised by im­
paired cognitive functions and neurochemical and 
structural abnormalities [2, 17, 18, 24, 25, 28]. The 
use of plant materials as neuroprotective agents has 
been reported by some researchers [7, 14, 20]. The 
extract of these herbal materials can restore hippoc­
ampal neurogenesis and improve cognitive dysfunc­
tion in diabetic animals [20]. 
Urtica L., the stinging nettle, a member of the 
Urticaceae family, is a perennial herb, distinguished 
by its stinging hairs [15]. Among the Urtica species, 
Urtica dioica (U. dioica) has long been known world­
wide as a medicinal plant. The blood sugar lower­
ing effect of U. dioica as a medicinal herb is referred 
to in old manuscripts, such as those written by Avi­
cenna [8]. In addition, U. dioica is among several 
species listed for their use against diabetes in folk 
medicine in a large pharmacological screen of Euro­
pean species [23]. 
The neuropreventive effects of U. dioica in the 
prevention and treatment of the cognitive compli­
cations of diabetes have not been clearly demon­
strated. This study was conducted to study the gran­
ule cell density of the dentate gyrus following ad­
ministration of Urtica dioica extract to diabetic rats. 
MATERIAL AND METHODS 
The study was performed in 2006–2007 in the 
Faculty of Medicine, Gorgan University of Medical 
Science. Approval for this study was gained from 
the Animal Care and Ethics Committee of the Gor­
gan University of Medical Sciences. 
Plant material 
U. dioica leaves were collected from cultivated 
plants, from a suburb of Gorgan, northern Iran (Go­
lestan, Iran) and taxonomically identified by the De­
partment of Pharmacognosy, Mazandaran Univer­
sity of Medical Sciences. A voucher specimen (5-77-1) 
was deposited in the herbarium of Mazandaran 
University. 
Preparation of plant extract 
The aerial parts of U. dioica were reduced to small 
pieces, dried in a circulating air stove and powdered 
in a grinder. The powdered material was then mac­
erated using a hydroalcoholic (60∞) solvent for 
48 hours. The ethanol was removed by vacuum dis­
tillation and the resulting residue was filtered and 
concentrated at 40∞C to make a jellied material. In 
addition to thin-layer chromatography and purity 
tests (for foreign matter, total ash, acid insoluble 
ash and water insoluble ash) for qualification analy­
sis, another monosaccharide-linked reagent assay 
(spectrophotometry) was carried out to determine 
the concentration of polysaccharides in the U. dio­
ica leaves for standardisation of the extract. The re­
sults of phytochemical analysis showed the exist­
ence of a high percentage of tannins and steroids 
and low levels of flavonoids, carotenoids and sa­
ponins in the leaves of U. dioica. 
At the time of administration the prepared pow­
der of the extract was dissolved in saline and the 
rats were treated with the solution. 
The animals and the hyperglycaemic model 
A total of 24 male albino Wistar rats aged 6–7 
postnatal weeks were provided by the Iranian Pasteur 
Institute. The rats, weighing 158.00 ± 42.09 g, were 
fed on a pellet diet and tap water ad libitum for full 
acclimatisation. During 5 weeks of the experiment the 
animals were kept in air-conditioned animal quarters 
(22 ± 2∞C) under a 12 hours light/dark cycle. To pre­
vent any confounding effects on hippocampal histol­
ogy, the environment was non-enriched. The rats were 
divided into four groups (n = 6) as follows: 
—	 control: no injection on the first day; saline daily 
2nd – 5th weeks; 
—	 diabetic: streptozotocin (STZ) injection on the 
first day; saline daily 2nd – 5th weeks; 
—	 preventive: hydroalcoholic extract of U. dioica, 
100 mg/kg/day, IP, over the first 5 days; STZ in­
jection in the 6th day; saline daily until the end of 
the experiment; 
—	 treatment: STZ injection on the first day; hydro-
alcoholic extract of U. dioica, 100 mg/kg/day, IP, 
2nd – 5th weeks. 
To produce a hyperglycaemic model on the first 
day of the experiment, the diabetes was induced 
with a single IP injection of STZ (80 mg/kg) to over­
night fasting rats. The STZ dose was determined by 
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Figure 1. Coronal sections stained with cresyl violet showing the hippcampal formation of the rat under light microscopy. A. The overall 
cytoarchitecture of hippocampal formation (40×); B. The zone of study was the outlined area in the dentate gyrus (100×); C, D, E. The 
zone of study with higher magnifications (200, 400, 1000×). The granule cells stained darkly and are clearly visible. SB — subiculum; 
DG — dentate gyrus; CA1 and CA3 — corona ammonis 1 and 3. 
a prior pilot study. Streptozotocin purchased from 
Sigma Co. was dissolved in saline and intraperit­
eonally injected. 
Blood glucose sampling 
Blood samples for glucose measurements were 
taken from the tail vein of the rats. Blood glucose con­
centrations were measured at the beginning of the 
1st, 2nd and 4th weeks using an ACCU-CHEK® Active Glu­
cometer, Roche Diagnostics GmbH, Germany. 
Glucose tolerance test 
The intraperitoneal glucose tolerance test (GTT) 
was performed on 16 hours fasted rats using 2 g 
dextrose per kg body weight at the beginning of 
the experiment. In all groups blood was collected 
from the animals by tail snipping at 0, 30, 90 and 
120 min after glucose load. The GTT was also per­
formed in the 5th week. 
Tissue processing 
The animals of the four groups were sacrificed 
following ether anaesthesia. The skulls of the rats 
were dissected and the brains collected. After mea­
surement of the total brain weights (i.e. hemispheres 
and cerebellum), the right hemispheres were sepa­
rated through the corpus callosum. The hemispheres 
were fixed in formaldehyde 10% for 48 hours and 
paraffin embedded. The 7 µm coronal sections were 
serially collected from Bregma –3.30 mm to –6.04 mm 
of the hippocampal formation [21]. An interval of 20 µm 
was placed between each two consecutive sections. 
The sections were stained with cresyl violet in accor­
dance with routine laboratory procedures. 
Morphometric study 
A photograph of each section was produced us­
ing an Olympus BX 51 microscope and a DP 12 dig­
ital camera under a magnification of 1000¥. An area 
of 10000 µm2 was selected in the hilar region of the 
dentate gyrus in all sections (Fig. 1). To measure the 
area density of the granule cells, the images were 
transferred to the computer. Using OLYSIA Auto­
bioreport software, Olympus Co, the appropriate 
grids were superimposed on the pictures and the 
cells were counted manually. To perform an unbi­
ased measurement, the individual was double-blind­
ed and only the cells with significant granule cell 
characteristics were counted. 
Statistical analysis 
All the data were entered into and analysed by 
SPSS 11.5 software. To compare the means of the 
measured parameters in the four groups by analy­
sis of variance (ANOVA) test, the normality of distri­
bution was first evaluated by the Kolmogorov­
198
 
S.A. Fazeli et al., Density of dentate granule cells in nettle-treated diabetic rats 
Figure 2. Glucose tolerance test of the four groups of the experiment at the beginning (left) and in the 5th week of the study (right). 
-Smirnov test and, after confirmation of normality, 
the means were compared by the ANOVA test. For 
pairwise comparison of the groups, the homogene­
ity of variance was tested by Levene’s test and, where 
there was homogeneity, comparison was made by 
a supplementary test of LSD. If there was no homo­
geneity, Dunnett’s T3 test was used. 
The correlations between granule cell density and 
the anterior-posterior position of the sections, mean 
glucose level at 5 weeks and the weight of the rat 
brain were individually examined by the Pearson 
correlation test. As the density may be affected by 
all the variables in a multi-factorial manner, the net 
effect of the variables mentioned on the density were 
tested with different multi-variable regression mod­
els by the “backward” method. 
RESULTS 
The GTT results of the four experimental groups 
at the beginning and in the 5th week of the study are 
presented in Figure 2. As shown, these were normal 
for all the rats at the beginning of the experiment. 
The GTT results at the end of the study showed 
a marked difference from the prior results for the rats 
receiving STZ, those of the diabetic, preventive and 
treatment groups. As shown in Figure 2, the control 
rats, which had not received STZ, showed a normal 
GTT. In contrast, the diabetic rats, which had under­
gone STZ-induced diabetes on the first day of study 
and had not received the nettle extract, showed the 
most profound impairment of GTT. The effects of 
prevention and treatment by nettle extract on the 
GTT results varied. Interestingly, the GTT of the pre­
ventive group showed a lower level of impairment 
than that of the rats treated by the nettle extract. 
Table 1 shows the brain weights, body weights 
and brain/body weight ratios of the experiments at 
the end of the study. Analysis of variance among 
the four groups using the ANOVA test showed that 
there were significant differences in these values in 
the four groups (p < 0.05). Levene’s test showed 
that variances of brain weight were homogeneous, 
and multiple comparisons between pairs of groups 
were carried out by the LSD test. 
The diabetic and treatment rats showed lower brain 
weights than the control group (p < 0.05). The ob­
served difference between the preventive and control 
rats was not statistically significant (p > 0.05). Howev­
er, because of the different body weights of the ani­
mals, a comparison of the brain/body weight ratios of 
the experimental animals seems to be more precise. As 
shown in Table 1, no significant difference was seen 
between the ratios of the diabetic and control groups 
(p > 0.05). Similary, the preventive group also showed 
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Table 1. Brain weights, body weights and brain/body weight ratios in the experimental groups at the end of study 
Group Brain weight [g] Body weight Brain/body weight ratio (%) 
Control 
Rat no. 1 
Rat no. 2 
Rat no. 3 
Rat no. 4 
Rat no. 5 
Rat no. 6 
Mean ±SD 
Diabetic 
Rat no. 1 
Rat no. 2 
Rat no. 3 
Rat no. 4 
Rat no. 5 
Rat no. 6 
Mean ±SD 
Preventive 
Rat no. 1 
Rat no. 2 
Rat no. 3 
Rat no. 4 
Rat no. 5 
Rat no. 6 
Mean ±SD 
Treatment 
Rat no. 1 
Rat no. 2 
Rat no. 3 
Rat no. 4 
Rat no. 5 
Rat no. 6 
Mean ±SD 
1.59 
1.72 
1.75 
1.70 
1.80 
1.67 
1.70 ± 0.07a, b,* 
1.62 
1.38 
1.17 
1.37 
1.18 
1.40 
1.35 ± 0.17a, c 
1.43 
1.51 
1.73 
1.63 
1.70 
1.57 
1.59 ± 0.11c 
1.47 
1.44 
1.57 
1.28 
1.53 
1.52 
1.46 ± 0.11b 
267.00 
222.00 
217.00 
231.00 
245.00 
190.00 
228.67 ± 26.14a, b, c 
173.00 
137.00 
147.00 
136.00 
138.00 
157.00 
148.00 ± 14.64a, d, e 
191.00 
147.00 
197.00 
190.00 
187.00 
163.00 
179.17 ± 19.66b, d, f 
101.00 
165.00 
105.00 
103.00 
121.00 
119.00 
119.00 ± 26.91c, e, f 
0.60 
0.77 
0.81 
0.74 
0.73 
0.88 
0.75 ± 0.09a 
0.94 
1.01 
0.80 
1.01 
0.85 
0.89 
0.91 ± 0.08b 
0.75 
1.03 
0.88 
0.86 
0.91 
0.96 
0.90 ± 0.09c 
1.45 
0.87 
1.49 
1.24 
1.26 
1.28 
1.27 ± 0.25a, b, c 
*The difference is significant at p < 0.05 level (a, b, c, d, e, f) 
no significatly different ratio compared to the control 
and diabetic rats (p > 0.05). In contrast, the rats treated 
by nettle extract after diabetes induction showed the 
highest ratio among the experimental groups (p < 0.05). 
The area densities of granule cells in the four groups 
of the experiment are shown in Table 2. The ANOVA 
test showed that there were no significant differences 
in the granule cell densities of the four groups (p > 
> 0.05). Considering the homogeneity of variances, the 
LSD test was chosen for multiple comparisons between 
pairs of the groups. The granule cell densities of the 
diabetic and preventive groups were lower than that 
of the control group, but no statistical significance was 
found (p > 0.05). The treatment group showed a high­
er density than the diabetic group (p > 0.05). In addi­
tion, the cell density of the treatment group was sig­
nificantly higher than that of the preventive group 
(p < 0.05). Interestingly, no significant difference was 
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Table 2. The area density of granule cells in the four experimental groups 
Area density Standard deviation Standard error of mean 
(count of granule cells/µm2) 
Control 7356 × 10-6 2118 × 10-6 299 × 10-6 
Diabetic 6896 × 10-6 1564 × 10-6 233 × 10-6 
Preventive 6804 × 10-6a 1412 × 10-6 187 × 10-6 
Treatment 7582 × 10-6a 2323 × 10-6 350 × 10-6 
a — the difference is significant at p < 0.05 
Figure 3. The anterior-posterior transitions of granule cell density in the four experimental groups; position is the distance [µm] of each 
section from the reference point. Granule cell density is the cell number in 1 µm2. See the text. 
found between the densities of the control and treat­
ment groups (p > 0.05). 
The individual correlations between granule cell 
density and the anterior-posterior position of the sec­
tion, mean glucose level at 5 weeks and rat brain 
weight were examined by the Pearson correlation test. 
When the data from all 24 rats were considered, 
it was apparent that the granule cell density was 
not correlated with the anterior-posterior position 
in which the density were measured (R = –0.095; 
p > 0.05). In contrast to this finding, the diabetic 
group showed a significant correlation between 
these variables (R = –0.464; p < 0.05). 
The Pearson correlation test showed controver­
sial correlations between granule cell density and 
brain weight. Taking the 24 as a whole, there was 
a negative correlation with no statistical significance 
between these two variables (R = –0.014; p > 0.05), 
whereas the treatment group showed a positive and 
significant correlation between them (R = 0.394; 
p < 0.05). The diabetic and control groups showed 
a significant negative correlation between granule 
cell density and brain weight (R = –0.322, –0.395 
respectively; p < 0.05). 
The granule cell densities of the rats in total and 
their mean glucose levels during 5 weeks of study 
were not correlated (R = –0.024; p > 0.05). In addi­
tion, only the protective group showed a significant 
correlation between them (R = –0.299; p > 0.05). 
The anterior-posterior transitions of granule cell 
density in the four groups of the experiment are 
shown in Figure 3. The horizontal axis shows the 
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Table 3. Multi-variable regression models showing the net effects of different factors on the granule cell density in 
different experimental groups 
Total D = 0.007 – 2.41 × 10-6 P P > 0.05; R2 = 0.009 
Control D = 0.030 – 0.013 B P < 0.05; R2 = 0.156 
Diabetic D = 0.008 – 9.07 × 10-6 P P < 0.05; R2 = 0.215 
Preventive  D = 0.008 – 3.74 × 10-6 G P < 0.05; R2 = 0.089 
Treatment D = –0.005 + 0.009 B P < 0.05; R2 = 0.155 
The significance was considered at p < 0.05; D — granule cell density; P — anterior-posterior position; G — mean glucose level of the 5 weeks; B — rat brain weight; 
R — coefficient of correlation. 
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relative anterior-posterior position of the sections 
from the reference position (i.e. Bregma –3.30 mm). 
The vertical axis represents the area densities of gran­
ule cells corresponding to the positions. 
The transitions showed that the anterior-poste­
rior distributions of granule cell density were not 
the same in the four groups, but some similarities 
between control and treatment groups were seen 
which could support the density results mentioned 
earlier. In addition, no significant regression model, 
including linear, quadratic and logarithmic, was 
compatible with the transitions drawn up (p > 0.05). 
It is difficult to imagine an anterior-posterior trend 
of granule-cell susceptibility to diabetes according 
to positional variability in the cell density. 
The net effect of the variables, including the an­
terior-posterior position of the section (P), mean glu­
cose level at 5 weeks (G) and rat brain weight (B) on 
the density (D), were shown in each of four groups 
using multi-variable regression models by the “back­
ward” method (Table 3). 
By the regression model, multi-variable equations 
such as D = a0 + a1P + a2B + a3G, were provided for 
the total sample as well as for each group. The back­
ward method tested the statistical significance of 
each component in all the suggested equations and 
finally proposed the most significant equations. As 
shown in Table 3, no uniform models were found 
with all three variables within one equation. This 
demonstrates that a significant multi-factorial model 
showing the net effect of the different variables on 
the density was not achieved either for the total 
sample or for each group. In addition, the effects of 
the variables on the density were not the same in 
the four groups. 
DISCUSSION 
The results of the present study showed a de­
crease in granule cell density following STZ-induced 
diabetes which was not statistically significant. In 
addition, the results suggest that the preventive 
administration of U. dioica extract used in this study 
showed no neuroprotective effect on granule cell 
loss in diabetic rats. In contrast, treatment with net­
tle extract in STZ-induced diabetic rats can help to 
restore the neuronal loss which is observed in dia­
betes. 
The decrease in cell density seen in the diabetic 
group was compatible with the results of previous 
studies. For example, Beauquis et al. [2] showed that 
neurons counted in the hilus of the dentate gyrus 
decreased by 30% in diabetic mice compared with 
controls. An explanation for this decrease in cell den­
sity can be the diminished proliferation of precursor 
neurons and new neuron survival, which have been 
demonstrated by various studies [2, 13, 24, 29]. In 
addition, involvement of cholinergic dysfunction, 
oxidative stress and inflammation in the develop­
ment of cognitive impairment in diabetic animals 
are factors that have been proposed by some stud­
ies [1, 7, 18]. 
The rats of the treatment groups showed no ev­
idence of granule cell loss, indicating that therapeu­
tic use of nettle extract may have significant regen­
erative effects on the granule cells and their pro­
genitors. It is now well documented that new neu­
rons produced in the subgranular zone arrive into 
granule cell layer of the dentate gyrus [10]. It has 
been suggested that granule cell death stimulates 
the proliferation of precursor cells, many of which 
survive and differentiate into mature granule neu­
rons and restore the granule cell loss in the dentate 
gyrus [11]. Given the results of the treatment group, 
it seems that nettle extract may enhance the pro­
duction of the new neurons and compensate for the 
diabetic-induced granule cell loss. 
The proposed neuroprotective property of net­
tle extract can be attributed to the antioxidant 
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activity of U. dioica. Increasing evidence suggests 
that oxidative stress plays an important role in dia­
betic neuropathology [1, 7, 18]. On the other hand, 
the antioxidant activity of U. dioica has also been 
shown by some studies [12, 22, 26]. These proper­
ties include inhibition of fatty acid peroxidation, 
effective reducing power, free radical scavenging, 
superoxide anion radical scavenging, hydrogen 
peroxide scavenging, and metal chelating activities, 
making the nettle extract a powerful natural anti­
oxidant material [12]. In addition, the level of free 
electron accumulation in several rat brain areas, 
such as the right frontal lobe, has fallen following 
nettle leaf supplementation [22, 26]. In conjunc­
tion with its antioxidant activity the nettle extract 
can also up-regulate AP-1 and may have an anti­
apoptotic and cell-survival supporting effect [26]. 
Given these properties, nettle extract may prevent 
oxidative injury and apoptotic cell death within the 
granule cell layer and subgranular zone of the den­
tate gyrus. Consequently, a lower number of ma­
ture and new granule cells would degenerate. In 
addition, the possible granule cell loss may be com­
pensated for by production of new granule neu­
rons within the subgranular zone. 
It was apparent that the preventive and thera­
peutic administration of nettle extract can have dif­
ferent outcomes. The preventive group of rats had 
the lowest granule cell density, and granule cell loss 
similar to that of the diabetic group was found in 
these rats. In contrast, the rats of the treatment 
group had the highest granule cell density and there 
was no diabetic-induced granule loss. To explain this 
finding, it should be borne in mind that the preven­
tion was limited to a short period before the diabe­
tes; but the treatment was continued for 28 days 
after STZ-induced diabetes. The prevention period 
may therefore be too short for the neuroprotective 
effects to appear. In addition, the preventive nettle 
extract was administered before the diabetes­
-induced loss had been established. As mentioned 
earlier, it has been shown that new neuron produc­
tion to reverse the granule cell loss is a lesion-in­
duced phenomenon [11]. As a result, it seems that 
prevention may not enhance the compensatory neu­
rogenesis, as discussed earlier with regard to thera­
peutic intervention. 
In conjunction with its main results, this study 
provided some supplementary data including GTT, 
brain weight, correlations and transitions. The GTT 
results, reflecting the insulin secretion states, sup­
port the preventive approach, as mild impairment 
was seen in the preventive group. This finding was 
not compatible with results regarding density which 
confirm a neuroprotective role for the treatment. On 
the other hand, a significant negative correlation 
between mean glucose level and density was found 
in the preventive groups but not in the treatment 
group. These findings together may suggest that 
the therapeutic effects of the nettle extract observed 
are not necessarily mediated by an improvement in 
insulin secretion and hyperglycaemic state. 
The results show that brain weight was not 
a specific indicator for the neuroprotective outcomes 
of nettle administration; because it can be affected 
by the body weight of the animal. To make a more 
precise comparison, an attempt was made to omit 
the effects of the body weight as a confounding 
variable and the brain/body weight ratio were pro­
posed. The results showed that the treatment groups 
had the highest ratio, which may support the treat­
ment rather than the prevention. However, it may 
not be specific either, because the changes in body 
weight can affect the results. 
An attempt was made to find the anterior-pos­
terior transitions of the density and provide the 
mathematical equations for computational analy­
sis. Transition of the cell density can show the dis­
tribution of the density in anterior-posterior transi­
tion. Moreover, the anterior-posterior trend of sus­
ceptibility can be discovered. In a similar manner, 
the multi-variable equation can show the net effect 
of all the variables on the density. 
The underlying trends of the transitions drawn 
up were not significantly describable by regression 
models, which show that the behaviour of the trait 
may be compatible with different models provided 
by neural network methods. Similarly, the results 
observed showed a considerable heterogeneity be­
tween the different groups and this was reflected 
by the lack of uniform equations. It was difficult 
therefore to propose a comprehensive multi-variable 
equation to represent the net effect of the all the 
variables on the density. 
CONCLUSION 
The study showed that Urtica dioica extract can 
help to restore diabetes-induced granule-cell loss in 
the rat dentate gyrus. However, preventive use of 
the extract showed no significant benefit. It seems 
that nettle extract administration can be a benefi­
cial treatment for the diabetic neuropathology in 
the dentate gyrus and that this can ameliorate cog­
nitive impairment in the diabetic patient. 
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